Skip to main navigation Skip to search Skip to main content

Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1

  • ATALANTE-1 study group

Research output: Contribution to journal › Article › peer-review

66 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases

Medicine and Dentistry